KATP channels mediate the antihypertrophic effects afforded by κ-opioid receptor stimulation in neonatal rat ventricular myocytes

Zhang,Lei; Wang,Hongxin; Lu,Meili; Wu,Guoqiang; Yang,Yuhong; Liu,Chunna; Maslov,L. N.

doi:10.3892/etm.2012.578

KATP channels mediate the antihypertrophic effects afforded by κ-opioid receptor stimulation in neonatal rat ventricular myocytes

Authors:
- Lei Zhang
- Hongxin Wang
- Meili Lu
- Guoqiang Wu
- Yuhong Yang
- Chunna Liu
- L. N. Maslov
View Affiliations

Affiliations: Key Laboratory of Molecular Biology and Drug Research, Liaoning Medical College, Jinzhou 121001, P.R. China, Laboratory of Experimental Cardiology, Institute of Cardiology, Tomsk 634012, Russia
Published online on: May 16, 2012 https://doi.org/10.3892/etm.2012.578
Pages: 261-266

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recent evidence suggests that κ-opioid receptor (OR) agonists and KATP channel activation exert antihypertrophic effects on cardiac myocytes. We studied the role of KATP channels in the antihypertrophic effects of ORs in primary cultures of neonatal rat ventricular myocytes exposed for 48 h to the α1 adrenoceptor agonist phenylephrine and the relative contributions of mitochondrial KATP (mitoKATP) and sarcolemmal KATP (sarcKATP). Furthermore, we elucidated the pathway between ORs and KATP channels and their impact on intracellular Ca2+ ([Ca2+]i) transients. Hypertrophy of cardiomyocytes was characterized by increases in i) total protein content; ii) cell size and iii) [3H]leucine incorporation. Phenylephrine (10 µM) increased the three parameters. Trans-(±)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]-benzeneacetamid methanesulfonate salt (U50,488H), a selective κ-opioid receptor agonist, prevented phenylephrine-induced hypertrophy and [Ca2+]i transients. The effect of U50,488H was abolished by nor-binaltorphimine, a selective κ-OR antagonist, indicating that the effect was κ-OR-mediated. The protein kinase C inhibitor chelerythrine and the KATP channel inhibitors glibenclamide (50 µM), a nonselective KATP antagonist, and 5-hydroxydecanoic acid (100 µM), a mitochondrial selective KATP antagonist, reversed the antihypertrophic effect of U50,488H, and there was no significant difference between the two KATP channel blockers. Moreover, we also determined the expression of the Kir6.2 subunits of the KATP channel, which increased in response to U50,488H in the presence of phenylephrine, but was suppressed by chelerythrine, glibenclamide and 5-hydroxydecanoic acid. U50,488H also attenuated the elevation of [Ca2+]i. This study suggests that KATP, and particularly the mitochondrial KATP, mediates the antihypertrophic effects of κ-opioid receptor stimulation via the PKC signaling pathway.

View Figures

View References

1.	Frey N and Olson EN: Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 65:45–79. 2003. View Article : Google Scholar : PubMed/NCBI
2.	Yu XC, Li HY, Wang HX and Wong TM: U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors. J Mol Cell Cardiol. 30:405–413. 1998. View Article : Google Scholar : PubMed/NCBI
3.	Shan D, Wang HX, Su YH, Jing Y and Wong TM: kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta1-adrenoceptor stimulation in the rat. Eur J Pharmacol. 555:100–105. 2007. View Article : Google Scholar : PubMed/NCBI
4.	Sanada S, Node K, Asanuma H, Ogita H, Takashima S and Minamino T: Opening of the adenosine triphosphatesensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase. J Am Coll Cardiol. 40:991–997. 2002. View Article : Google Scholar
5.	Xia Y, Rajapurohitam V, Cook MA and Karmazyn M: Inhibition of phenylephrine induced hypertrophy in rat neonatal cardiomyocytes by the mitochondrial K_ATP channel opener diazoxide. J Mol Cell Cardiol. 37:1063–1067. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Seino S and Miki T: Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol. 81:133–176. 2003.
7.	Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB and D Alonzo AJ: Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels: possible mechanism of cardioprotection. Circ Res. 81:1072–1082. 1997.
8.	Oldenburg O, Cohen MV, Yellon DM and Downey JM: Mitochondrial K_ATP channels: role in cardioprotection. Cardiovasc Res. 55:429–437. 2002.
9.	Chen M, Zhou JJ, Kam KW, Qi JS, Yan WY and Wong TM: Roles of K_ATP channels in delayed cardioprotection and intracellular Ca²⁺ in the rat heart as revealed by κ-opioid receptor stimulation with U50,488H. Br J Pharmacol. 140:750–758. 2003.
10.	Light PE, Kanji HD, Fox JE and French RJ: Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial K_ATP channels during metabolic inhibition and recovery. FASEB J. 15:2586–2594. 2001. View Article : Google Scholar : PubMed/NCBI
11.	Pei JM, Wang YM, Zhu YL, Chen M and Wong TM: Signaling pathway mediated by kappa-opioid receptor is impaired in cardiac hypertrophy. Acta Pharmacol Sin. 22:887–895. 2001.PubMed/NCBI
12.	Huh J, Gross GJ, Nagase H and Liang BT: Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K_ATP channels. Am J Physiol Heart Circ Physiol. 280:H377–383. 2001.PubMed/NCBI
13.	Wang Y, Hirai K and Ashraf M: Activation of mitochondrial ATP-sensitive K+ channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res. 85:731–734. 1999.
14.	Zukin RS, Eghbali M, Olive D, Unterwald EM and Tempel A: Characterization and visualization of rat and guinea pig brain kappa-opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors. Proc Natl Acad Sci. 85:4061–4065. 1988. View Article : Google Scholar : PubMed/NCBI
15.	Rothman RB, Bykov V, Costa BR, Jacobson AE, Rice KC and Brady LS: Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides. 11:311–331. 1990. View Article : Google Scholar : PubMed/NCBI
16.	Portoghese PS, Lipkowski AW and Takemori AE: Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci. 40:1287–1292. 1987. View Article : Google Scholar : PubMed/NCBI
17.	Takemori AE, Ho BY, Naeseth JS and Portoghese PS: Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther. 246:255–258. 1988.PubMed/NCBI
18.	Tortella FC, Echevarria E, Lipkowski AW, Takemori AE, Portoghese PS and Holaday JW: Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci. 44:661–665. 1989. View Article : Google Scholar : PubMed/NCBI
19.	Tai KK, Bian CF and Wong TM: kappa-opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci. 51:909–913. 1992. View Article : Google Scholar : PubMed/NCBI
20.	Ventura C, Spurgeon H, Lakatta EG, Guarnieri C and Capogrossi MC: kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca²⁺ release from an intra-cellular pool in myocytes and neurons. Circ Res. 70:66–81. 1992. View Article : Google Scholar : PubMed/NCBI
21.	Sheng JZ and Wong TM: Chronic U50,488H abolishes inositol-1,4,5-trisphosphate and intracellular Ca²⁺ elevations evoked by kappa-opioid receptor in rat myocytes. Eur J Pharmacol. 307:323–329. 1996. View Article : Google Scholar : PubMed/NCBI
22.	Xia Y, Javadov S, Gan TX, Pang T, Cook MA and Karmazyn M: Distinct K_ATP channels mediate the antihypertrophic effects of adenosine receptor activation in neonatal rat ventricular myocytes. J Pharmacol Exp Ther. 320:14–21. 2007.
23.	Simpson P and Savion S: Differentiation of rat myocytes in single cell cultures with and without proliferation nonmyocardial cells. Cross-striations, ultrastructure, and chromotropic response to isoproterenol. Circ Res. 50:101–116. 1982. View Article : Google Scholar
24.	Berk BC, Vekshtein V, Gordon HM and Tsuda T: Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 13:305–314. 1989. View Article : Google Scholar : PubMed/NCBI
25.	Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275. 1951.PubMed/NCBI
26.	Zheng JS, Boluyt MO, Long X, O Neill L, Lakatta EG and Crow MT: Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ Res. 78:525–535. 1996. View Article : Google Scholar : PubMed/NCBI
27.	Luo JD, Xie F, Zhang WW, Ma XD, Guan JX and Chen X: Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. Br J Pharmacol. 132:159–164. 2001. View Article : Google Scholar : PubMed/NCBI
28.	Grynkiewicz G, Poenie M and Tsien RY: A new generation of Ca²⁺ indicators with greatly improved fluorescence properties. J Biol Chem. 260:3440–3450. 1985.
29.	Patel HH, Ludwig LM, Fryer RM, Hsu AK, Warltier DC and Gross GJ: Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K_ATP channel opening. FASEB J. 16:1468–1470. 2002.PubMed/NCBI
30.	Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A and Terzic A: Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol. 275:1567–1576. 1998.
31.	Seymour EM, Wu SY, Kovach MA, Romano MA, Traynor JR, Claycomb WC and Bolling SF: HL-1 myocytes exhibit PKC and K_ATP channel-dependent delta opioid preconditioning. J Surg Res. 114:187–194. 2003. View Article : Google Scholar : PubMed/NCBI
32.	Fryer RM, Wang Y, Hsu AK and Gross GJ: Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol. 280:H1346–1353. 2001.PubMed/NCBI
33.	Ping P, Zhang J, Pierce WM and Bolli R Jr: Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res. 88:59–62. 2001. View Article : Google Scholar : PubMed/NCBI
34.	Hu K, Duan D, Li GR and Nattel S: Protein kinase C activates ATP-sensitive K+ current in human and rabbit ventricular myocytes. Circ Res. 78:492–498. 1996.
35.	Fryer RM, Hsu AK, Eells JT, Nagase H and Gross GJ: Opioid-induced second window of cardioprotection: potential role of mitochondrial K_ATP channels. Circ Res. 84:846–851. 1999. View Article : Google Scholar : PubMed/NCBI